Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced oesophageal squamous cell carcinoma: a single-Centre, open-label, randomized, controlled, clinical trial (HCHTOG1903)

Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced oesophageal squamous cell carcinoma: a single-Centre, open-label, randomized, controlled, clinical trial (HCHTOG1903)

Abstract Background Neoadjuvant therapy plus oesophagectomy has been accepted as the standard treatment for patients with potentially curable locally advanced oesophageal cancer. No completed randomized controlled trial (RCT) has directly compared neoadjuvant chemotherapy and neoadjuvant chemoradiat...

Full description

Bibliographic Details
Main Authors: Hai-Bo Sun, Wen-Qun Xing, Xian-Ben Liu, Yan Zheng, Shu-Jun Yang, Zong-Fei Wang, Shi-Lei Liu, Yu-Feng Ba, Rui-Xiang Zhang, Bao-Xing Liu, Cheng-Cheng Fan, Pei-Nan Chen, Guang-Hui Liang, Yong-Kui Yu, Qi Liu, Hao-Ran Wang, Hao-Miao Li, Zhen-Xuan Li, written on Henan Cancer Hospital Thoracic Oncology Group (HCHTOG)
Format: Article
Language:English
Published: BMC 2020-04-01
Series:BMC Cancer
Subjects:
Oesophagus
Squamous cell carcinoma
Neoadjuvant chemotherapy
Neoadjuvant chemoradiotherapy
Online Access:http://link.springer.com/article/10.1186/s12885-020-06824-2

Internet

http://link.springer.com/article/10.1186/s12885-020-06824-2

Similar Items